Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 325412, 7 pages
http://dx.doi.org/10.1155/2013/325412
Research Article

Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma

Department of Dermatology, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Aoba-ku, Sendai 980-8574, Japan

Received 31 July 2013; Revised 16 October 2013; Accepted 30 October 2013

Academic Editor: Gianluca Matteoli

Copyright © 2013 Taku Fujimura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Taku Fujimura, Yumi Kambayashi, Sadanori Furudate, Aya Kakizaki, and Setsuya Aiba, “Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma,” Clinical and Developmental Immunology, vol. 2013, Article ID 325412, 7 pages, 2013. https://doi.org/10.1155/2013/325412.